These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15229206)

  • 1. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
    Ibáñez L; De Zegher F
    Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
    Ibáñez L; Jaramillo AM; Ferrer A; de Zegher F
    Hum Reprod; 2005 Sep; 20(9):2457-62. PubMed ID: 15905296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
    Ibáñez L; De Zegher F
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
    Ibáñez L; Valls C; Cabré S; De Zegher F
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4716-20. PubMed ID: 15356085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.
    Ibáñez L; de Zegher F
    Hum Reprod; 2003 Jan; 18(1):57-60. PubMed ID: 12525441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2005 Jan; 90(1):39-43. PubMed ID: 15483105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
    Ibáñez L; Díaz M; López-Bermejo A; de Zegher F
    Gynecol Endocrinol; 2011 Mar; 27(3):197-8. PubMed ID: 20528210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
    Ibáñez L; de Zegher F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
    Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio.
    Ibáñez L; Valls C; de Zegher F
    Hum Reprod; 2006 Feb; 21(2):451-6. PubMed ID: 16239318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients.
    Kebapcilar L; Kebapcilar AG; Bilgir O; Taner CE; Bozkaya G; Yildiz Y; Sari I
    Gynecol Endocrinol; 2011 Feb; 27(2):91-5. PubMed ID: 20528207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.
    Lázaro I; Díaz M; Cabré A; Masana L; Ibáñez L
    Gynecol Endocrinol; 2011 Nov; 27(11):935-9. PubMed ID: 21605000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
    Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.
    Ibáñez L; López-Bermejo A; Díaz M; Enríquez G; Del Río L; De Zegher F
    Gynecol Endocrinol; 2010 Dec; 26(12):869-73. PubMed ID: 20500100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome.
    Hadžiomerović-Pekić D; Wildt L; Weiss JM; Moeller K; Mattle V; Seeber BE
    Fertil Steril; 2010 Nov; 94(6):2385-8. PubMed ID: 20356587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
    Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
    Mitkov M; Pehlivanov B; Terzieva D
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):209-13. PubMed ID: 15653205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.